CA1014469A - Steroid formulation for topical application - Google Patents

Steroid formulation for topical application

Info

Publication number
CA1014469A
CA1014469A CA183,683A CA183683A CA1014469A CA 1014469 A CA1014469 A CA 1014469A CA 183683 A CA183683 A CA 183683A CA 1014469 A CA1014469 A CA 1014469A
Authority
CA
Canada
Prior art keywords
topical application
steroid formulation
steroid
formulation
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA183,683A
Other languages
English (en)
Other versions
CA183683S (en
Inventor
Matthew A. Augustine
Louis T. Difazio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA1014469A publication Critical patent/CA1014469A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
CA183,683A 1972-11-24 1973-10-18 Steroid formulation for topical application Expired CA1014469A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US309295A US3892857A (en) 1972-11-24 1972-11-24 Steroid formulation

Publications (1)

Publication Number Publication Date
CA1014469A true CA1014469A (en) 1977-07-26

Family

ID=23197591

Family Applications (1)

Application Number Title Priority Date Filing Date
CA183,683A Expired CA1014469A (en) 1972-11-24 1973-10-18 Steroid formulation for topical application

Country Status (11)

Country Link
US (1) US3892857A (ko)
JP (1) JPS5726243B2 (ko)
BE (1) BE807753A (ko)
CA (1) CA1014469A (ko)
DE (1) DE2355710C2 (ko)
FR (1) FR2207692B1 (ko)
GB (1) GB1444989A (ko)
IE (1) IE39957B1 (ko)
NL (1) NL7315922A (ko)
PH (1) PH10338A (ko)
ZA (1) ZA738130B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4065452A (en) * 1976-08-02 1977-12-27 Syntex (U.S.A.) Inc. 21,21-Dihalo steroids
DE2851544C2 (de) * 1978-11-29 1985-09-26 Beiersdorf Ag, 2000 Hamburg Fluocortolon-haltige Creme
AU5794680A (en) * 1979-05-31 1980-12-04 E.R. Squibb & Sons, Inc. Corticosteroid stick formulations
EP0020794B1 (en) * 1979-06-08 1983-01-12 Toko Yakuhin Kogyo Kabushiki Kaisha Creamy preparation containing steroid and process for the preparation thereof
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
DE3109459A1 (de) * 1981-03-09 1982-09-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen (delta)(pfeil hoch)9(pfeil hoch)(pfeil hoch)((pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch)1(pfeil hoch)(pfeil hoch))(pfeil hoch)- und (delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)6(pfeil hoch)-21-chlor-20-keto-steroide der pregnan- und d-homo-pregnan-reihe, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte fuer die synthese von hochwirksamen corticoiden
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4914090A (en) * 1985-11-01 1990-04-03 Schering Corporation Ophthalmic compositions
JPH0735330B2 (ja) * 1986-03-12 1995-04-19 久光製薬株式会社 外用クリ−ム組成物
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
US5432170A (en) * 1991-07-16 1995-07-11 Schering Aktiengesellschaft Process for the production of semisolid preparations containing micronized active ingredients
ATE162080T1 (de) * 1991-07-16 1998-01-15 Schering Ag Verfahren zur herstellung von mikronisierte wirkstoffe enthaltende halbfeste zubereitungen
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
WO2009045539A2 (en) 2007-10-05 2009-04-09 Nektar Therapeutics Al, Corporation Oligomer-corticosteroid conjugates
JP4891207B2 (ja) * 2007-11-27 2012-03-07 大洋香料株式会社 抗菌剤及びそれを含有する皮膚外用剤
FR3138377B1 (fr) 2022-07-26 2024-06-14 Psa Automobiles Sa Véhicule automobile comportant un système de restitution d’images du moteur thermique à l’utilisateur dudit véhicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3694471A (en) * 1970-06-08 1972-09-26 Warner Lambert Pharmaceutical 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides

Also Published As

Publication number Publication date
ZA738130B (en) 1974-08-28
JPS4981520A (ko) 1974-08-06
BE807753A (fr) 1974-05-24
NL7315922A (ko) 1974-05-28
FR2207692A1 (ko) 1974-06-21
US3892857A (en) 1975-07-01
FR2207692B1 (ko) 1976-05-14
DE2355710C2 (de) 1985-04-25
IE39957L (en) 1974-05-24
PH10338A (en) 1976-12-09
AU6165273A (en) 1975-04-24
GB1444989A (en) 1976-08-04
IE39957B1 (en) 1979-02-14
DE2355710A1 (de) 1974-05-30
JPS5726243B2 (ko) 1982-06-03

Similar Documents

Publication Publication Date Title
CA1014469A (en) Steroid formulation for topical application
AU471577B2 (en) Anti-inflammatory steroid aerosol formulations
CA950828A (en) Polylactide-drug mixtures for topical application
CA1017672A (en) Dermatological compositions
AU483797B2 (en) Dermatological compositions
CA977503A (en) Rinse-wax formulation
CA992545A (en) Cyclohexenone derivatives
CA1007221A (en) Pregnane acid derivatives
CA1020546A (en) 21-sulfinyl steroids
CA1014856A (en) Anti-inflammatory topical gel
CA894207A (en) Therapeutic compositions for topical application
AU476313B2 (en) Steroid glycosides
AU478859B2 (en) Steroid derivatives
AU489087B2 (en) n TOPICAL STEROID
AU482224B2 (en) Steroid formulation
AU6068273A (en) Steroid derivatives
AU7073674A (en) n TOPICAL STEROID
AU5931473A (en) Applicator for weedicides
CA995663A (en) Anti-inflammatory steroid and processes for its preparation
AU491072B2 (en) Topical steriod formulation
AU485903B2 (en) 2-2-dimethyl steroids
CA1002939A (en) Steroids
CA895284A (en) Steroids
CA892018A (en) 6-gem-difluoro steroids
CA891486A (en) A-furan steroids